
Patients can get real-time disease monitoring with self-operated device.
Patients can get real-time disease monitoring with self-operated device.
Changes are resulting in better outcomes for patients with glaucoma.
Investigators learn that a wearable aid can offer improved mobility.
Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.
Technology can track the progression of retinal abnormalities
Lens an option for complicated eyes, astigmatism, monovision candidates.
Pilot study shows promise of teaching surgeons with technology.
Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography.
Cotargeted therapy could help combat inherited retinal diseases.
Taking control of a practice’s future with investment, creative thinking
Heru Inc., announced Thursday that it has partnered with Vision Source on the commercial availability launch of re:Vive, a wearable diagnostics and visual field application.
Telemedicine provides readiness in time of crisis.
Trifocal IOLs can, if implanted with caution, be suitable for patients with keratoconus.
Mitch Shultz, MD, speaks on the capabilities of a cloud-based database system to look at energy-fluid metrics, provide surgeons with the capacity to refine procedures and give patients better outcomes.
Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia.
Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.
Although minimally invasive procedure gives hope, additional research is required.
Holographic technology offers after-surgery glimpse for surgeons, patients.
Technology enables physicians to provide and receive important information more quickly.
Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.
MedShr Insights has developed an early warning system that applies natural language processing, artificial intelligence, and machine learnings.
Retinal imaging tests are providing material to train and test decision-support systems.
According to investigators, the new technology is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late.
Physicians are finding a wealth of information that is readily available.